Literature DB >> 7954866

The epidemiology of AL and AA amyloidosis.

R W Simms1, M N Prout, A S Cohen.   

Abstract

The limited available epidemiological information on AL amyloidosis suggests that there may be differences between population-based studies and case series data with respect to variables such as age and racial patterns. Much more work in this area is required before specific aetiologic hypotheses can be tested. Most available data to approximate the epidemiology of AA amyloidosis are derived from autopsies. Most patients with AA amyloidosis die from causes other than amyloidosis, therefore mortality data based on death certificates is of limited value in AA amyloidosis. Case ascertainment in autopsy studies may be difficult due to the frequent lack of adequate histological controls. Establishment of registries for both AL and AA amyloidosis would facilitate epidemiological research in these disorders.

Entities:  

Mesh:

Year:  1994        PMID: 7954866     DOI: 10.1016/s0950-3579(05)80119-0

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  17 in total

1.  Amyloidosis and the risk of cancer: a nationwide population-based study.

Authors:  Vincent Yi-Fong Su; Chia-Jen Liu; Yu-Wen Hu; Wei-Juin Su; Yuh-Min Chen; Shinn-Liang Lai; Tzeng-Ji Chen; Diahn-Warng Perng; Yu-Chin Lee; Cheng-Hwai Tzeng; Kun-Ta Chou
Journal:  Int J Clin Oncol       Date:  2015-06-04       Impact factor: 3.402

2.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 3.  Current perspectives on cardiac amyloidosis.

Authors:  Jian Guan; Shikha Mishra; Rodney H Falk; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

4.  Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics.

Authors:  T M El Mansoury; B P C Hazenberg; S A El Badawy; A H Ahmed; J Bijzet; P C Limburg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

5.  Risks of Ventricular Tachyarrhythmia and Mortality in Patients with Amyloidosis - A Long-Term Cohort Study.

Authors:  Yun-Yu Chen; Ming-Jen Kuo; Fa-Po Chung; Yenn-Jiang Lin; Kuo-Liong Chien; Yu-Cheng Hsieh; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Tze-Fan Chao; Jo-Nan Liao; Ting-Yung Chang; Chin-Yu Lin; Ling Kuo; Ta-Chuan Tuan; Cheng-I Wu; Chih-Min Liu; Shin-Huei Liu; Cheng-Hung Li; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2022-07       Impact factor: 1.800

6.  Revisiting secondary amyloidosis for an inadequately investigated feature: dyslipidemia.

Authors:  Serhan Piskinpasa; Hadim Akoglu; Eyup Koc; Fatma Dogru; Ezgi Yenigun Coskun; Didem Turgut; Nihal Ozkayar; Ramazan Ozturk; Ali Riza Odabas; Fatih Dede
Journal:  Rheumatol Int       Date:  2012-07-31       Impact factor: 2.631

Review 7.  Currents concepts on the immunopathology of amyloidosis.

Authors:  Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

8.  Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis.

Authors:  Kevin M Alexander; John Orav; Avinainder Singh; Sophia A Jacob; Adil Menon; Robert F Padera; Marie F Kijewski; Ronglih Liao; Marcelo F Di Carli; Jacob P Laubach; Rodney H Falk; Sharmila Dorbala
Journal:  JAMA Cardiol       Date:  2018-09-01       Impact factor: 14.676

9.  Lung cancer combined with diffuse peritoneal and mesenteric amyloidosis detected on 18F-FDG PET/CT: A case report.

Authors:  JianJie Wang; Bin Zhao; Tianbin Song; Jidong Sun
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

10.  Nephrotic Syndrome Associated with Lung Cancer: A Rare Case of Malignancy Associated with AA Amyloidosis.

Authors:  Victor Gueutin; Anne-Lyse Langlois; Nathalie Shehwaro; Ryme Elharraqui; Philippe Rouvier; Hassane Izzedine
Journal:  Case Rep Nephrol       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.